Aytu BioPharma (AYTU) Competitors $1.50 +0.05 (+3.45%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends AYTU vs. OKYO, ELEV, OTLK, ANEB, LTRN, VRCA, BCAB, RNXT, MRKR, and PMNShould you be buying Aytu BioPharma stock or one of its competitors? The main competitors of Aytu BioPharma include OKYO Pharma (OKYO), Elevation Oncology (ELEV), Outlook Therapeutics (OTLK), Anebulo Pharmaceuticals (ANEB), Lantern Pharma (LTRN), Verrica Pharmaceuticals (VRCA), BioAtla (BCAB), RenovoRx (RNXT), Marker Therapeutics (MRKR), and ProMIS Neurosciences (PMN). These companies are all part of the "pharmaceutical products" industry. Aytu BioPharma vs. OKYO Pharma Elevation Oncology Outlook Therapeutics Anebulo Pharmaceuticals Lantern Pharma Verrica Pharmaceuticals BioAtla RenovoRx Marker Therapeutics ProMIS Neurosciences Aytu BioPharma (NASDAQ:AYTU) and OKYO Pharma (NASDAQ:OKYO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends. Which has more risk & volatility, AYTU or OKYO? Aytu BioPharma has a beta of -1.4, indicating that its share price is 240% less volatile than the S&P 500. Comparatively, OKYO Pharma has a beta of -0.19, indicating that its share price is 119% less volatile than the S&P 500. Does the MarketBeat Community prefer AYTU or OKYO? Aytu BioPharma received 247 more outperform votes than OKYO Pharma when rated by MarketBeat users. However, 100.00% of users gave OKYO Pharma an outperform vote while only 67.11% of users gave Aytu BioPharma an outperform vote. CompanyUnderperformOutperformAytu BioPharmaOutperform Votes25567.11% Underperform Votes12532.89% OKYO PharmaOutperform Votes8100.00% Underperform VotesNo Votes Do institutionals & insiders have more ownership in AYTU or OKYO? 33.5% of Aytu BioPharma shares are owned by institutional investors. Comparatively, 3.0% of OKYO Pharma shares are owned by institutional investors. 2.8% of Aytu BioPharma shares are owned by insiders. Comparatively, 40.5% of OKYO Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is AYTU or OKYO more profitable? OKYO Pharma has a net margin of 0.00% compared to Aytu BioPharma's net margin of -8.28%. OKYO Pharma's return on equity of 0.00% beat Aytu BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets Aytu BioPharma-8.28% -21.89% -5.37% OKYO Pharma N/A N/A N/A Which has better earnings and valuation, AYTU or OKYO? Aytu BioPharma has higher revenue and earnings than OKYO Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAytu BioPharma$79.76M0.12-$15.84M-$1.23-1.22OKYO PharmaN/AN/A-$16.83MN/AN/A Do analysts recommend AYTU or OKYO? OKYO Pharma has a consensus target price of $7.00, indicating a potential upside of 557.28%. Given OKYO Pharma's stronger consensus rating and higher possible upside, analysts clearly believe OKYO Pharma is more favorable than Aytu BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aytu BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00OKYO Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to AYTU or OKYO? In the previous week, Aytu BioPharma's average media sentiment score of 0.00 equaled OKYO Pharma'saverage media sentiment score. Company Overall Sentiment Aytu BioPharma Neutral OKYO Pharma Neutral SummaryOKYO Pharma beats Aytu BioPharma on 9 of the 13 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get Aytu BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AYTU vs. The Competition Export to ExcelMetricAytu BioPharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.22M$6.71B$5.23B$9.28BDividend YieldN/A3.00%5.12%4.28%P/E Ratio-1.2210.6387.7717.30Price / Sales0.12196.091,168.55119.64Price / CashN/A57.1543.2337.83Price / Book0.325.164.834.93Net Income-$15.84M$151.58M$120.63M$225.49M7 Day Performance11.94%4.16%2.84%4.14%1 Month Performance-4.46%-3.95%19.70%1.16%1 Year Performance-48.45%10.41%30.57%17.00% Aytu BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AYTUAytu BioPharma0.9263 of 5 stars$1.50+3.4%N/A-48.5%$9.22M$79.76M-1.22160Positive NewsOKYOOKYO Pharma1.6063 of 5 stars$1.05-0.9%$7.00+566.7%-40.2%$35.53MN/A0.007ELEVElevation Oncology1.9352 of 5 stars$0.58-0.1%$7.20+1,143.1%+20.0%$34.24MN/A-0.7140OTLKOutlook Therapeutics1.8884 of 5 stars$1.41-2.1%$42.34+2,904.1%-82.6%$33.34MN/A-0.1320ANEBAnebulo Pharmaceuticals2.0092 of 5 stars$1.28+29.6%$8.00+523.7%-37.7%$33.26MN/A-4.284News CoverageGap DownHigh Trading VolumeLTRNLantern Pharma0.9313 of 5 stars$3.02-4.1%N/A-23.7%$32.57MN/A-1.7020VRCAVerrica Pharmaceuticals4.7228 of 5 stars$0.71+1.7%$9.50+1,245.6%-89.9%$32.19M$9.21M-0.3940BCABBioAtla2.7225 of 5 stars$0.64-7.5%$6.00+837.4%-72.2%$30.95M$11M-0.3860Gap UpHigh Trading VolumeRNXTRenovoRx1.2638 of 5 stars$1.28+2.0%$6.50+409.8%+25.2%$30.60MN/A-2.246Positive NewsGap UpMRKRMarker Therapeutics4.4471 of 5 stars$3.42-10.0%$19.00+455.6%-14.9%$30.52M$3.31M0.0060Insider TradeNews CoveragePMNProMIS Neurosciences0.6492 of 5 stars$0.92-0.2%N/A-12.1%$30.01M$10,000.00-9.186Positive News Related Companies and Tools Related Companies OKYO Pharma Alternatives Elevation Oncology Alternatives Outlook Therapeutics Alternatives Anebulo Pharmaceuticals Alternatives Lantern Pharma Alternatives Verrica Pharmaceuticals Alternatives BioAtla Alternatives RenovoRx Alternatives Marker Therapeutics Alternatives ProMIS Neurosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AYTU) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
